Prescription RequiredGeftinat contains GEFITINIB 250 mg, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC), especially in patients with EGFR gene mutations.
| Generic Name | Gefitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets |
| Prescribed For | Lung Cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Tablets | $120 | £90 | A$180 | NZ$198 | ₱6,816 | ₩161,400 | lei 516 | HK$936 | RM498 | ฿3,816 | د.إ441 |
Gefitinib prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
